STEVE JOHNSON: Open Payments
NPI 1144338880 · JASPER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,604 in 134 payments from 23 companies in 2025. Trend: 2023 $2,494 · 2024 $2,660 · 2025 $2,604
Food & beverage: $2,604
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $388 |
| AstraZeneca Pharmaceuticals LP | 14 | $313 |
| ABBVIE INC. | 15 | $287 |
| Corcept Therapeutics | 11 | $245 |
| PFIZER INC. | 10 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $188 |
| Dexcom, Inc. | 9 | $135 |
| Otsuka America Pharmaceutical, Inc. | 10 | $135 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| Eisai Inc. | 4 | $88 |
Products named: Korlym, Wegovy, AIRSUPRA, VRAYLAR, TRINTELLIX, Dexcom G6 Transmitter, REXULTI, Ozempic.
Industry payments across AL — which companies pay providers there.
